Severe Asthma Epidemiology Forecast

DelveInsight's "Severe Asthma - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Severe Asthma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2019-2032

Severe Asthma Understanding

The DelveInsight Severe Asthma epidemiology report gives a thorough understanding of the Severe Asthma by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Severe Asthma in the US, Europe, and Japan. The report covers the detailed information of the Severe Asthma epidemiology scenario in seven major countries (US, EU5, and Japan).

Severe Asthma Epidemiology Perspective by DelveInsight

The Severe Asthma epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Severe Asthma epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Severe Asthma epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Severe Asthma Detailed Epidemiology Segmentation

The Severe Asthma epidemiology covered in the report provides historical as well as forecasted Severe Asthma epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

 

The DelveInsight Severe Asthma report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

  • The Severe Asthma report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Severe Asthma Epidemiology Report and Model provide an overview of the global trends of Severe Asthma in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight into the historical and forecasted patient pool of Severe Asthma in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps recognize the growth opportunities in the 7MM for the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Severe Asthma
  • The report provides the segmentation of the Severe Asthma epidemiology

Report Highlights

  • 11-year Forecast of Severe Asthma epidemiology
  • 7MM Coverage
  • Prevalent and Diagnosed Cases of Severe Asthma
  • Cases of Severe Asthma by Mutation Types
  • Severe Asthma Cases associated with Clinical Manifestations

KOL views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Severe Asthma?
  • What are the key findings pertaining to the Severe Asthma epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2019-2032)?
  • What would be the total number of patients of Severe Asthma across the 7MM during the forecast period (2019-2032)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
  • What is the disease risk, burden and unmet needs of Severe Asthma?
  • What are the currently available treatments of Severe Asthma?

Reasons to buy

The Severe Asthma Epidemiology report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the global Severe Asthma market
  • Quantify patient populations in the global Severe Asthma market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Severe Asthma therapeutics in each of the markets covered
  • Understand the magnitude of Severe Asthma population by its epidemiology
  • The Severe Asthma Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Severe Asthma

3. Severe Asthma: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Severe Asthma Epidemiology Scenario in the 7MM (2019- 2032)

5.4. United States Epidemiology

5.4.1. Severe Asthma Epidemiology Scenario in the United States (2019- 2032)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Severe Asthma Epidemiology Scenario in Germany (2019- 2032)

5.5.2. France Epidemiology

5.5.2.1. Severe Asthma Epidemiology Scenario in France (2019- 2032)

5.5.3. Italy Epidemiology

5.5.3.1. Severe Asthma Epidemiology Scenario in Italy (2019- 2032)

5.5.4. Spain Epidemiology

5.5.4.1. Severe Asthma Epidemiology Scenario in Spain (2019- 2032)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Severe Asthma Epidemiology Scenario in the United Kingdom (2019-2032)

5.6. Japan Epidemiology

5.6.1. Severe Asthma Epidemiology Scenario in Japan (2019- 2032)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Severe Asthma Treatment and Management

6.2. Severe Asthma Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

List of Tables

Table 1:  Severe Asthma Epidemiology in 7MM (2019-2032)

Table 2: Severe Asthma Diagnosed and Treatable Cases in 7MM (2019-2032)

Table 3: Severe Asthma Epidemiology in the United States (2019-2032)

Table 4: Severe Asthma Diagnosed and Treatable Cases in the United States (2019-2032)

Table 5: Severe Asthma Epidemiology in Germany (2019-2032)

Table 6: Severe Asthma Diagnosed and Treatable Cases in Germany (2019-2032)

Table 7: Severe Asthma Epidemiology in France (2019-2032)

Table 8: Severe Asthma Diagnosed and Treatable Cases in France (2019-2032)

Table 9: Severe Asthma Epidemiology in Italy (2019-2032)

Table 10: Severe Asthma Diagnosed and Treatable Cases in Italy (2019-2032)

Table 11: Severe Asthma Epidemiology in Spain (2019-2032)

Table 12: Severe Asthma Diagnosed and Treatable Cases in Spain (2019-2032)

Table 13: Severe Asthma Epidemiology in the United Kingdom (2019-2032)

Table 14: Severe Asthma Diagnosed and Treatable Cases in the United Kingdom (2019-2032)

Table 15: Severe Asthma Epidemiology in Japan (2019-2032)

Table 16: Severe Asthma Diagnosed and Treatable Cases in Japan (2019-2032)

List of Figures

Figure 1 Severe Asthma Epidemiology in 7MM (2019-2032)

Figure 2 Severe Asthma Diagnosed and Treatable Cases in 7MM (2019-2032)

Figure 3 Severe Asthma Epidemiology in the United States (2019-2032)

Figure 4 Severe Asthma Diagnosed and Treatable Cases in the United States (2019-2032)

Figure 5  Severe Asthma Epidemiology in Germany (2019-2032)

Figure 6  Severe Asthma Diagnosed and Treatable Cases in Germany (2019-2032)

Figure 7  Severe Asthma Epidemiology in France (2019-2032)

Figure 8 Severe Asthma Diagnosed and Treatable Cases in France (2019-2032)

Figure 9 Severe Asthma Epidemiology in Italy (2019-2032)

Figure 10 Severe Asthma Diagnosed and Treatable Cases in Italy (2019-2032)

Figure 11 Severe Asthma Epidemiology in Spain (2019-2032)

Figure 12 Severe Asthma Diagnosed and Treatable Cases in Spain (2019-2032)

Figure 13 Severe Asthma Epidemiology in the United Kingdom (2019-2032)

Figure 14 Severe Asthma Diagnosed and Treatable Cases in the United Kingdom (2019-2032)

Figure 15 Severe Asthma Epidemiology in Japan (2019-2032)

Figure 16 Severe Asthma Diagnosed and Treatable Cases in Japan (2019-2032)

*The table of contents is not exhaustive; will be provided in the final report

Forward to Friend

Need A Quote